List of articles with "Celltrion"

FDA Approves OMLYCLO® 300mg

FDA Approves OMLYCLO® 300mg

South Korea Incheon Celltrion OMLYCLO XOLAIR
ZYMFENTRA® Efficacy Insights

ZYMFENTRA® Efficacy Insights

South Korea Crohn's Disease Incheon Celltrion ZYMFENTRA
Kaigene Partners with Celltrion

Kaigene Partners with Celltrion

United States Rockville Celltrion antibody therapeutics Kaigene
Celltrion's Biosimilars Approved

Celltrion's Biosimilars Approved

USA Incheon Celltrion STOBOCLO OSENVELT
WellsCare & Celltrion Unite

WellsCare & Celltrion Unite

South Korea Seoul Celltrion WellsCare IASO
FDA Expands YUFLYMA® Usage

FDA Expands YUFLYMA® Usage

United States Incheon Celltrion YUFLYMA® Adalimumab
EYDENZELT® Receives FDA Approval

EYDENZELT® Receives FDA Approval

South Korea FDA Approval Incheon Celltrion EYDENZELT
AVTOZMA® Launch

AVTOZMA® Launch

United States Incheon Celltrion AVTOZMA® Tocilizumab
AVTOZMA® Receives FDA Approval

AVTOZMA® Receives FDA Approval

Celltrion AVTOZMA® Cytokine Release Syndrome
Celltrion's New Biosimilars

Celltrion's New Biosimilars

USA Jersey City Celltrion STOBOCLO OSENVELT
STEQEYMA® Expanded

STEQEYMA® Expanded

South Korea FDAApproval Incheon Celltrion STEQEYMA
YUFLYMA® Achieves FDA Designation

YUFLYMA® Achieves FDA Designation

South Korea Incheon Celltrion Humira YUFLYMA
YUFLYMA® Receives FDA Approval

YUFLYMA® Receives FDA Approval

None Celltrion Humira YUFLYMA
Celltrion's IBD Highlights

Celltrion's IBD Highlights

South Korea Inflammatory Bowel Disease Incheon Celltrion ZYMFENTRA
YUFLYMA® Gains FDA Approval

YUFLYMA® Gains FDA Approval

USA Incheon Celltrion Humira YUFLYMA
STEQEYMA® Launched

STEQEYMA® Launched

USA Jersey City Celltrion Stelara® STEQEYMA®
First Interchangeable Biosimilar

First Interchangeable Biosimilar

United States Jersey City Celltrion OMLYCLO XOLAIR
Celltrion FDA Approval

Celltrion FDA Approval

Jersey City Celltrion STOBOCLO OSENVELT
AVTOZMA® FDA Approval

AVTOZMA® FDA Approval

USA FDA Jersey City Celltrion AVTOZMA
Celltrion's Innovative Drug Strategy

Celltrion's Innovative Drug Strategy

South Korea Drug Development J.P. Morgan Incheon Celltrion

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.